TalkMed Group (SGX:5G3) ROE % Adjusted to Book Value : 11.54% (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is TalkMed Group ROE % Adjusted to Book Value?

TalkMed Group's ROE % for the quarter that ended in Dec. 2024 was 81.44%. TalkMed Group's PB Ratio for the quarter that ended in Dec. 2024 was 7.06. TalkMed Group's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 11.54%.

TalkMed Group ROE % Adjusted to Book Value Historical Data

The historical data trend for TalkMed Group's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TalkMed Group ROE % Adjusted to Book Value Chart

TalkMed Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

3.96

5.04

5.72

6.44

7.13

TalkMed Group Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															6.88	5.23	7.39	3.61	11.54

Competitive Comparison of TalkMed Group's ROE % Adjusted to Book Value

For the Medical Care Facilities subindustry, TalkMed Group's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TalkMed Group's ROE % Adjusted to Book Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TalkMed Group's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where TalkMed Group's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

TalkMed Group ROE % Adjusted to Book Value Calculation

TalkMed Group's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	50.31%	/	7.06
	=	7.13%

TalkMed Group's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	81.44%	/	7.06
	=	11.54%

TalkMed Group ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of TalkMed Group's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

TalkMed Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TalkMed Group Ltd (SGX:5G3) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

3 Mount Elizabeth, Mount Elizabeth Hospital Level 2, Singapore, SGP, 228510

Website

https://www.talkmed.com.sg

TalkMed Group Ltd operates as an investment holding company. It is a provider of medical oncology, stem cell transplants and palliative care services, serving patients in Singapore and the region. Outside Singapore, the Group operates in Vietnam, Hong Kong and the People's Republic of China. The activities of the company are the provision of medical oncology services and palliative care healthcare services in Singapore. It is organized into two reportable operating segments, Oncology Services and Cellular and gene therapy-related products and services. The company has operational footprints across Singapore, China and Hong Kong, Australia, Vietnam and others of which Singapore contributes the vast majority of total revenue. It generates maximum revenue from the Oncology services segment.

TalkMed Group Headlines

No Headlines